questionsmedicales.fr
Maladies de l'appareil digestif
Maladies du foie
Hépatite
Hépatites virales humaines
Hépatites virales humaines : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Hépatite virale
Tests de laboratoire
Hépatite C
Polymerase Chain Reaction
Symptômes
5
Hépatite B
Douleur abdominale
Hépatite C
Symptômes chroniques
Asymptomatique
Hépatite virale
Prévention
5
Hygiène
Hépatites virales
Traitements
5
Hépatite C
Traitement antiviral
Complications
5
Hépatite C
Insuffisance hépatique
Cancer du foie
Hépatites virales
Facteurs de risque
5
Hépatite B
Facteurs de risque
Hépatite C
Drogues injectables
Travailleurs de la santé
Hépatites virales
Immunodépression
Hépatites virales
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hépatites virales humaines : Questions médicales les plus fréquentes",
"headline": "Hépatites virales humaines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hépatites virales humaines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-11",
"dateModified": "2025-04-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hépatites virales humaines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hépatite",
"url": "https://questionsmedicales.fr/mesh/D006505",
"about": {
"@type": "MedicalCondition",
"name": "Hépatite",
"code": {
"@type": "MedicalCode",
"code": "D006505",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.552.380"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hépatite A",
"alternateName": "Hepatitis A",
"url": "https://questionsmedicales.fr/mesh/D006506",
"about": {
"@type": "MedicalCondition",
"name": "Hépatite A",
"code": {
"@type": "MedicalCode",
"code": "D006506",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.552.380.705.422"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hépatite B",
"alternateName": "Hepatitis B",
"url": "https://questionsmedicales.fr/mesh/D006509",
"about": {
"@type": "MedicalCondition",
"name": "Hépatite B",
"code": {
"@type": "MedicalCode",
"code": "D006509",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.552.380.705.437"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hépatite C",
"alternateName": "Hepatitis C",
"url": "https://questionsmedicales.fr/mesh/D006526",
"about": {
"@type": "MedicalCondition",
"name": "Hépatite C",
"code": {
"@type": "MedicalCode",
"code": "D006526",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.552.380.705.440"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hépatite D",
"alternateName": "Hepatitis D",
"url": "https://questionsmedicales.fr/mesh/D003699",
"about": {
"@type": "MedicalCondition",
"name": "Hépatite D",
"code": {
"@type": "MedicalCode",
"code": "D003699",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.552.380.705.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hépatite E",
"alternateName": "Hepatitis E",
"url": "https://questionsmedicales.fr/mesh/D016751",
"about": {
"@type": "MedicalCondition",
"name": "Hépatite E",
"code": {
"@type": "MedicalCode",
"code": "D016751",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.552.380.705.470"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hépatites virales humaines",
"alternateName": "Hepatitis, Viral, Human",
"code": {
"@type": "MedicalCode",
"code": "D006525",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Robert Thimme",
"url": "https://questionsmedicales.fr/author/Robert%20Thimme",
"affiliation": {
"@type": "Organization",
"name": "Klinik für Innere Medizin II - Gastroenterologie, Hepatologie, Endokrinologie, Infektiologie, Universitätsklinikum Freiburg, Freiburg, Deutschland. robert.thimme@uniklinik-freiburg.de."
}
},
{
"@type": "Person",
"name": "Fabien Zoulim",
"url": "https://questionsmedicales.fr/author/Fabien%20Zoulim",
"affiliation": {
"@type": "Organization",
"name": "INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon, Lyon, France."
}
},
{
"@type": "Person",
"name": "Emmanuelle Jouanguy",
"url": "https://questionsmedicales.fr/author/Emmanuelle%20Jouanguy",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR-1163, Necker Hospital for Sick Children, Paris, France. emmanuelle.jouanguy@inserm.fr."
}
},
{
"@type": "Person",
"name": "Christoph Neumann-Haefelin",
"url": "https://questionsmedicales.fr/author/Christoph%20Neumann-Haefelin",
"affiliation": {
"@type": "Organization",
"name": "Klinik für Innere Medizin II - Gastroenterologie, Hepatologie, Endokrinologie, Infektiologie, Universitätsklinikum Freiburg, Freiburg, Deutschland."
}
},
{
"@type": "Person",
"name": "C-Thomas Bock",
"url": "https://questionsmedicales.fr/author/C-Thomas%20Bock",
"affiliation": {
"@type": "Organization",
"name": "Division of Viral Gastroenteritis and Hepatitis Pathogens and Enteroviruses, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany. BockC@rki.de."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Alprostadil for hypertensive nephropathy: A systematic review and meta-analysis of randomized controlled trials.",
"datePublished": "2022-05-26",
"url": "https://questionsmedicales.fr/article/35617324",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0269111"
}
},
{
"@type": "ScholarlyArticle",
"name": "Efficacy of administrative intervention for neurosurgical patients with off-label use of alprostadil lipid microsphere.",
"datePublished": "2022-09-13",
"url": "https://questionsmedicales.fr/article/36100635",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-19717-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of Alprostadil Combined with Edaravone on Inflammation, Oxidative Stress and Pulmonary Function in Patients with Traumatic Hemorrhagic Shock.",
"datePublished": "2022-08-31",
"url": "https://questionsmedicales.fr/article/36800822",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.14715/cmb/2022.68.8.22"
}
},
{
"@type": "ScholarlyArticle",
"name": "Application of Nanoliposome Alprostadil in the Perioperative Period of Percutaneous Coronary Intervention to Reduce In-Stent Restenosis: A Systematic Review and Meta-Analysis.",
"datePublished": "2023-05-18",
"url": "https://questionsmedicales.fr/article/37251365",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2023/4100197"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effectiveness of Alprostadil for Ductal Patency.",
"datePublished": "2024-02-07",
"url": "https://questionsmedicales.fr/article/38332962",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.5863/1551-6776-29.1.37"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies de l'appareil digestif",
"item": "https://questionsmedicales.fr/mesh/D004066"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies du foie",
"item": "https://questionsmedicales.fr/mesh/D008107"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hépatite",
"item": "https://questionsmedicales.fr/mesh/D006505"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hépatites virales humaines",
"item": "https://questionsmedicales.fr/mesh/D006525"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hépatites virales humaines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hépatites virales humaines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hépatites virales humaines",
"description": "Comment diagnostiquer une hépatite virale ?\nQuels tests sont utilisés pour l'hépatite B ?\nPeut-on diagnostiquer l'hépatite C par PCR ?\nQuels sont les signes d'une hépatite aiguë ?\nL'échographie est-elle utile pour l'hépatite ?",
"url": "https://questionsmedicales.fr/mesh/D006525?mesh_terms=Alprostadil#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hépatites virales humaines",
"description": "Quels sont les symptômes de l'hépatite A ?\nL'hépatite B provoque-t-elle des douleurs abdominales ?\nQuels symptômes indiquent une hépatite C chronique ?\nL'hépatite D a-t-elle des symptômes spécifiques ?\nPeut-on avoir des symptômes sans hépatite ?",
"url": "https://questionsmedicales.fr/mesh/D006525?mesh_terms=Alprostadil#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hépatites virales humaines",
"description": "Comment prévenir l'hépatite A ?\nQuelles mesures pour éviter l'hépatite B ?\nLe vaccin contre l'hépatite C existe-t-il ?\nComment se protéger contre l'hépatite D ?\nL'hygiène peut-elle prévenir l'hépatite ?",
"url": "https://questionsmedicales.fr/mesh/D006525?mesh_terms=Alprostadil#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hépatites virales humaines",
"description": "Quel est le traitement de l'hépatite A ?\nComment traiter l'hépatite B chronique ?\nL'hépatite C se traite-t-elle efficacement ?\nY a-t-il un vaccin pour l'hépatite B ?\nQuels sont les traitements pour l'hépatite D ?",
"url": "https://questionsmedicales.fr/mesh/D006525?mesh_terms=Alprostadil#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hépatites virales humaines",
"description": "Quelles complications peuvent survenir avec l'hépatite B ?\nL'hépatite C peut-elle causer des problèmes hépatiques ?\nQuelles sont les conséquences de l'hépatite A ?\nL'hépatite D aggrave-t-elle d'autres hépatites ?\nPeut-on développer un cancer du foie avec l'hépatite ?",
"url": "https://questionsmedicales.fr/mesh/D006525?mesh_terms=Alprostadil#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hépatites virales humaines",
"description": "Quels sont les facteurs de risque pour l'hépatite B ?\nQui est à risque d'hépatite C ?\nL'hépatite A est-elle liée à des voyages ?\nLes travailleurs de la santé sont-ils à risque d'hépatite ?\nLes personnes immunodéprimées sont-elles plus à risque ?",
"url": "https://questionsmedicales.fr/mesh/D006525?mesh_terms=Alprostadil#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une hépatite virale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins pour détecter les marqueurs viraux et les enzymes hépatiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour l'hépatite B ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests HBsAg, anti-HBs et anti-HBc sont couramment utilisés pour l'hépatite B."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer l'hépatite C par PCR ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la PCR détecte l'ARN du virus de l'hépatite C dans le sang, confirmant l'infection."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une hépatite aiguë ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent jaunisse, fatigue, douleurs abdominales et nausées."
}
},
{
"@type": "Question",
"name": "L'échographie est-elle utile pour l'hépatite ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'échographie peut évaluer l'état du foie et détecter des anomalies."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'hépatite A ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, fièvre, nausées, et jaunisse."
}
},
{
"@type": "Question",
"name": "L'hépatite B provoque-t-elle des douleurs abdominales ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs dans la partie supérieure droite de l'abdomen peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une hépatite C chronique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue persistante, douleurs articulaires et jaunisse peuvent indiquer une hépatite C chronique."
}
},
{
"@type": "Question",
"name": "L'hépatite D a-t-elle des symptômes spécifiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes sont similaires à ceux de l'hépatite B, mais peuvent être plus graves."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans hépatite ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent être asymptomatiques malgré une infection virale."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hépatite A ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination et l'hygiène alimentaire sont essentielles pour prévenir l'hépatite A."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter l'hépatite B ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des préservatifs et éviter le partage d'aiguilles sont des mesures clés."
}
},
{
"@type": "Question",
"name": "Le vaccin contre l'hépatite C existe-t-il ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin efficace contre l'hépatite C."
}
},
{
"@type": "Question",
"name": "Comment se protéger contre l'hépatite D ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination contre l'hépatite B protège également contre l'hépatite D."
}
},
{
"@type": "Question",
"name": "L'hygiène peut-elle prévenir l'hépatite ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne hygiène des mains et des aliments réduit le risque d'hépatites virales."
}
},
{
"@type": "Question",
"name": "Quel est le traitement de l'hépatite A ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement spécifique ; le repos et l'hydratation sont recommandés."
}
},
{
"@type": "Question",
"name": "Comment traiter l'hépatite B chronique ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antiviraux comme l'entécavir ou le ténofovir sont utilisés pour contrôler l'infection."
}
},
{
"@type": "Question",
"name": "L'hépatite C se traite-t-elle efficacement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements antiviraux à action directe peuvent guérir l'hépatite C dans la plupart des cas."
}
},
{
"@type": "Question",
"name": "Y a-t-il un vaccin pour l'hépatite B ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vaccin contre l'hépatite B est efficace pour prévenir l'infection."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements pour l'hépatite D ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement de l'hépatite D est limité ; l'interféron peut être utilisé dans certains cas."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'hépatite B ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la cirrhose et le cancer du foie."
}
},
{
"@type": "Question",
"name": "L'hépatite C peut-elle causer des problèmes hépatiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'hépatite C peut entraîner une cirrhose et une insuffisance hépatique."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences de l'hépatite A ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hépatite A est généralement bénigne, mais peut causer des complications rares comme l'insuffisance hépatique."
}
},
{
"@type": "Question",
"name": "L'hépatite D aggrave-t-elle d'autres hépatites ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'hépatite D peut aggraver l'hépatite B, augmentant le risque de complications."
}
},
{
"@type": "Question",
"name": "Peut-on développer un cancer du foie avec l'hépatite ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections chroniques par l'hépatite B ou C augmentent le risque de cancer du foie."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour l'hépatite B ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le partage d'aiguilles, les rapports sexuels non protégés et la transfusion sanguine."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'hépatite C ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes ayant des antécédents de consommation de drogues injectables sont à risque élevé."
}
},
{
"@type": "Question",
"name": "L'hépatite A est-elle liée à des voyages ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones à forte prévalence d'hépatite A augmente le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les travailleurs de la santé sont-ils à risque d'hépatite ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont exposés à un risque accru d'hépatite B et C par contact avec le sang."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont plus susceptibles de développer des infections hépatiques graves."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 07/04/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Klinik für Innere Medizin II - Gastroenterologie, Hepatologie, Endokrinologie, Infektiologie, Universitätsklinikum Freiburg, Freiburg, Deutschland. robert.thimme@uniklinik-freiburg.de.
Publications dans "Hépatites virales humaines" :
3 publications dans cette catégorie
Affiliations :
INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon, Lyon, France.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR-1163, Necker Hospital for Sick Children, Paris, France. emmanuelle.jouanguy@inserm.fr.
Imagine Institute, Paris University, Paris, France. emmanuelle.jouanguy@inserm.fr.
St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY, USA. emmanuelle.jouanguy@inserm.fr.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Klinik für Innere Medizin II - Gastroenterologie, Hepatologie, Endokrinologie, Infektiologie, Universitätsklinikum Freiburg, Freiburg, Deutschland.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Division of Viral Gastroenteritis and Hepatitis Pathogens and Enteroviruses, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany. BockC@rki.de.
Institute of Tropical Medicine, University of Tübingen, Tubingen, Germany. BockC@rki.de.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Departments of Laboratory Medicine and Infectious Diseases and Obstetrics & Gynecology, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China. Electronic address: zgr03summer@126.com.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Liver Unit, Hospital Universitario Valle Hebron and Civerehd del Instituto Carlos III, Barcelona, Spain.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine 1, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham Heersink School of Medicine, 1917 Clinic Dewberry, 3220 5th Avenue South, Room 1044A, Birmingham, AL 35222, USA. Electronic address: rfranco@uabmc.edu.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine II, University Hospital Freiburg, Freiburg, Germany.
IMM-PACT Clinician Scientist Programme, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Emergency Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Microbiology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
CIBEREHD, Instituto de Salud Carlos III, Madrid, Spain.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
CIBEREHD, Instituto de Salud Carlos III, Madrid, Spain.
Biochemistry Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Liver Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
CIBEREHD, Instituto de Salud Carlos III, Madrid, Spain.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Liver Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
CIBEREHD, Instituto de Salud Carlos III, Madrid, Spain.
Publications dans "Hépatites virales humaines" :
2 publications dans cette catégorie
Affiliations :
Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
Publications dans "Hépatites virales humaines" :
1 publication dans cette catégorie
Affiliations :
St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.
Publications dans "Hépatites virales humaines" :
1 publication dans cette catégorie
Affiliations :
Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY.
Publications dans "Hépatites virales humaines" :
1 publication dans cette catégorie
Affiliations :
Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.
Paris Descartes University, Imagine Institute, Paris, France.
Publications dans "Hépatites virales humaines" :
1 publication dans cette catégorie
Affiliations :
Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY.
Publications dans "Hépatites virales humaines" :
We performed a meta-analysis to evaluate the efficacy of alprostadil in the treatment of hypertensive nephropathy. Seven online databases (PubMed, Embase, Cochrane Library, China National Knowledge In...
As an adjuvant drug, alprostadil lipid microsphere injection (Lipo-PGE...
The study aimed to explore the roles of alprostadil combined with edaravone in inflammation, oxidative stress and Pulmonary function in patients with traumatic hemorrhagic shock (HS). 80 patients with...
In-stent restenosis (ISR) is a common complication after percutaneous coronary intervention (PCI) surgery for patients with coronary atherosclerotic heart disease (CHD). Reports indicate alprostadil m...
Articles were searched from databases, and meta-analysis was performed in Review Manager software. Funnel plots were performed to evaluate the publication bias, and sensitivity analysis was performed ...
Initially, 113 articles were identified, and 5 studies of 463 subjects were included for analysis eventually. The primary endpoint, i.e., the occurrence of ISR after PCI, occurred in 11.91% of the alp...
This study aims to describe the effectiveness of low initial alprostadil dosages to maintain a patent ductus arteriosus (PDA) in infants with ductal-dependent congenital heart disease (DDCHD). Seconda...
This retrospective observational cohort study at the British Columbia's Women's and Children's Hospital neonatal intensive care unit and pediatric intensive care unit examined neonates admitted with D...
Alprostadil was effective for 88% of patients, with no difference between the very low-dose and low-dose groups. Of the 75 patients included, 25 received very low-dose alprostadil. Adverse drug events...
Alprostadil therapy was effective in maintaining the PDA in neonates with DDCHD with low-dosage regimens. Adverse drug events were common with both dosage regimens; however, the very low dosage appear...
The aim is to investigate the clinical efficacy of Alprostadil in diabetes mellitus (DM) combined with peripheral atherosclerosis and to investigate the molecular mechanisms....
Patients included 154 cases with DM combined with peripheral atherosclerosis and were divided into the conventional group (77 cases) and the Alprostadil group (77 cases). Both groups of patients were ...
The total effective rate of treatment in the Alprostadil group was higher than that in the conventional group. The biochemical indices of whole blood viscosity, plasma viscosity, erythrocyte pressure ...
Clinically, the use of Alprostadil as an adjunct to conventional therapy for the treatment of DM combined with peripheral atherosclerosis has high clinical efficacy. In addition, Alprostadil has a sig...
To evaluate the long-term efficacy of transoral incisionless fundoplication (TIF) with Medigus Ultrasonic Surgical Endostapler (MUSE) for gastroesophageal reflux disease (GERD)....
A total of 16 patients with proton pump inhibitor-dependent gastroesophageal reflux disease had undergone TIF by MUSE in Shanghai General Hospital (Shanghai, China)from March 2017 to December 2018. Pa...
Follow-up data were collected from 13 patients, ranging from 38 to 63 months, 53 months on average. 10/13 patients reported symptomatic improvement and daily PPI consumption was stopped or halved in 1...
TIF by MUSE has significant efficacy in the treatment of PPI-dependent GERD, which can improve symptoms and life quality of patients, and reduce the acid exposure time for long-term. Chictr.org.cn....
ChiCTR2000034350....
To compare four diffusion-weighted imaging (DWI) sequences for image quality, rectal contour, and lesion conspicuity, and to assess the difference in their signal-to-noise ratio (SNR) and contrast-to-...
In this retrospective study of 36 consecutive patients who underwent 3.0 T rectal MRI from January-June 2020, DWI was performed with single-shot echo planar imaging (ss-EPI) (b800 s/mm...
For both readers, MUSE b800 scored significantly higher for image quality, rectal contour, and lesion conspicuity compared to ss-EPI; MUSE b800 also scored significantly higher for image quality and r...
MUSE b800 improved image quality over ss-EPI and both MUSE b800 and b1500 showed better tumor conspicuity compared to conventional ss-EPI....
We describe an original minimally invasive penile plication technique with scrotal or infrapubic access, not requiring circumcision, for penile curvature of different severity and types. This techniqu...
Between 2012 and 2018 we treated 134 patients suffering from congenital curvature (33) and acquired curvature from Peyronie's disease (101). The average curvature was 62.2° (± 30.4°). Preoperative eva...
Complete correction of penile curvature was achieved in 96.8 % of patients. No major complications were reported, and no patients suffered worsening in erectile function or in penile sensitivity. The ...
This is a simple and rapid technique that perfectly corrects even the most severe and complex penile curvatures. In comparison to traditional techniques, such as Nesbit procedure, this technique is as...
Type 1 interferons play a key role in the pathogenesis of systemic lupus erythematosus (SLE). An important clinical question is whether inhibiting the type 1 interferon pathway reduce the disease acti...
Key terms (SLE, type 1 interferon, anifrolumab) were used to query the PubMed database for phase 1, 2 and 3 clinical trials of anifrolumab for SLE patients. Phase 1 studies showed anifrolumab has non-...
Anifrolumab is an exciting new therapeutic for SLE patients. Additional analyses of the combined TULIP-1 and TULIP-2 datasets as well as future studies with anifrolumab will generate yet more data in ...